For the year ending 2025-12-31, FBRX has $82,779K in assets. $21,788K in debts. $76,957K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 76,957 | |||
| Prepaid expenses and other current assets | 3,632 | |||
| Total current assets | 80,589 | |||
| Property and equipment, at cost | 241 | |||
| Less accumulated depreciation | 112 | |||
| Property and equipment, net | 129 | |||
| Other assets | 2,061 | |||
| Total assets | 82,779 | |||
| Accounts payable | 9,989 | |||
| Accrued liabilities | 10,762 | |||
| Total current liabilities | 20,751 | |||
| Income tax payable | 1,037 | |||
| Total liabilities | 21,788 | |||
| Common stock, 0.001 par value 200,000,000 shares authorized as of december 31, 2025 and december 31, 2024 12,948,308 and 6,393,323 shares issued and outstanding at december 31, 2025 and december 31, 2024, respectively | 13 | |||
| Additional paid-in capital | 284,348 | |||
| Accumulated other comprehensive income | 3 | |||
| Accumulated deficit | -223,373 | |||
| Total stockholders equity | 60,991 | |||
| Total liabilities and stockholders' equity | 82,779 | |||
Forte Biosciences, Inc. (FBRX)
Forte Biosciences, Inc. (FBRX)